drugset / Trial / NCT05968118
Angiogenesis and Blood Perfusion Effect of HGF Gene Therapy in PAD Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate whether PET/CT-RGD or MIBI can be used for the angiogenesis assessment of NL003 in PAD patients.
Timeline
- Start
- 2022-07-29
- Primary completion
- 2023-07-31
- Completion
- 2023-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NL003 | Other / unclassified | 8 mg | Intramuscular |